Pasi Jänne: key facts
- Kind of voice
- Academic
- Role
- M.D., Ph.D., lung cancer specialist at Dana-Farber Cancer Institute
- Quoted on
- Respiratory (asthma/COPD)
- Press citations held
- 1
- Most recently quoted
- 29 Sept 2026
“At the moment, screening for lung cancer is based, essentially, solely on tobacco exposure. Here we've identified a genetic component that is also a risk factor, and maybe these are individuals that would benefit from screening and early detection to identify cancers at an earlier early stage when they're still potentially curable.”
Where Pasi Jänne has been quoted
- Rare EGFR mutation increases lung cancer risk 62 times in never smokersfiercebiotech.com · 29 Sept 2026
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 30 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.